Alpha Crest Capital Management LLC Royalty Pharma PLC Transaction History

Alpha Crest Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $834,449 - $934,256	20,924 Added 77.44%	47,943 $1.93 Million
Q2 2022 Aug 11, 2022	SELL	$37.53 - $44.22 $1.26 Million - $1.49 Million	-33,669 Reduced 55.48%	27,019 $1.14 Million
Q1 2022 May 12, 2022	BUY	$37.46 - $42.44 $1.37 Million - $1.55 Million	36,495 Added 150.85%	60,688 $2.36 Million
Q4 2021 Feb 09, 2022	SELL	$35.17 - $42.48 $2.11 Million - $2.55 Million	-60,062 Reduced 71.29%	24,193 $964,000
Q3 2021 Nov 10, 2021	BUY	$36.14 - $42.24 $3.04 Million - $3.56 Million	84,255 New	84,255 $3.05 Million

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.